Treatment preferences of patients and physicians for early-stage and adjuvant treatment of urothelial carcinoma and renal cell carcinoma in Asia-Pacific: a discrete choice experiment

Patients and physicians valued efficacy attributes over TRAE-attributes. Both groups would trade higher risks for greater efficacy, though these trade-offs vary based on TRAE type. This indicates a need for shared decision-making for early-stage and adjuvant UC and RCC in Asia-Pacific.

Authors

Institutions

Publication Details

Journal
BMC Urology
Published
2026-01-16
DOI
https://doi.org/10.1186/s12894-025-02043-8
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment preferences of patients and physicians for early-stage and adjuvant treatment of urothelial carcinoma and renal cell carcinoma in Asia-Pacific: a discrete choice experiment

E. S. Y. Chan, Edmund Chiong, L. Spain, Teng-Aik Ong et al.
BMC Urology
Bladder and Urothelial Cancer Treatments
article

Treatment preferences of patients and physicians for early-stage and adjuvant treatment of urothelial carcinoma and renal cell carcinoma in Asia-Pacific: a discrete choice experiment

E. S. Y. Chan, Edmund Chiong, L. Spain, Teng-Aik Ong, Sameer Gokhale, Anilda D’Souza, Yu-Chieh Tsai, Manish I. Patel, Lawrence Vandervoort, Shian Shiang Wang, Jeremy Yuen-Chun Teoh
article en

Abstract

Patients and physicians valued efficacy attributes over TRAE-attributes. Both groups would trade higher risks for greater efficacy, though these trade-offs vary based on TRAE type. This indicates a need for shared decision-making for early-stage and adjuvant UC and RCC in Asia-Pacific.

BMC Urology
National University of Singapore (SG), National Taiwan University (TW), Chinese University of Hong Kong (HK), Peter MacCallum Cancer Centre (AU), Westmead Hospital (AU), University of Malaya (MY), Taichung Veterans General Hospital (TW), Chinese University of Hong Kong, Shenzhen (CN), Serdia Pharmaceuticals (India) (IN), National Taiwan University Hospital (TW), National University Hospital (SG), MSD (India) (IN), Medical University of Vienna (AT)
Good health and well-being
Openalex Percentile: Top 87%
Bladder and Urothelial Cancer Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Treatment preferences of patients and physicians for early-stage and adjuvant treatment of urothelial carcinoma and renal cell carcinoma in Asia-Pacific: a discrete choice experiment — E. S. Y. Chan, Edmund Chiong, et al. · BMC Urology (2026) | TGRS Research Map | TGRS